HepaRegeniX Secures €15 Million Series C Funding to Propel Clinical Development of HRX-215 for Liver Regeneration

HepaRegeniX GmbH, a pioneering clinical-stage biotechnology firm specializing in regenerative therapies for liver diseases, has announced the successful closure of a Series C funding round totaling €15 million. Led by Vesalius Biocapital IV and supported by existing investors including Novo Holdings, Boehringer Ingelheim Venture Fund (BIVF), and High-Tech Gründerfonds (HTGF), this investment will accelerate the…

Read More

HarmonyCares Raises $200 Million to Expand In-Home Primary Care Access Nationwide

HarmonyCares, a trailblazer in value-based in-home primary care, has secured $200 million in funding to extend its innovative care model to more patients across the United States. The investment, led by General Catalyst, McKesson Ventures, and a major national payor, alongside K2 HealthVentures and existing investors, marks a significant step towards addressing the critical gap…

Read More

AlphaSense Secures $930 Million Acquisition of Tegus, Advancing AI-Driven Market Intelligence

AlphaSense, the renowned market intelligence platform leveraging AI, has finalized its acquisition of Tegus, a prominent provider of expert research and financial data solutions. The acquisition, valued at $930 million, marks a significant milestone for AlphaSense, further bolstered by a newly closed $650 million funding round co-led by Viking Global Investors and BDT & MSD…

Read More

Active Membranes Secures Seed Funding to Propel Revolutionary Desalination Technology

Active Membranes, a trailblazer in desalination technology known for its innovative electrically-conducting membranes, has successfully closed its initial round of Seed Funding aimed at advancing its groundbreaking water purification solutions. The investment will fuel further corporate expansion, technology scaling, and the execution of extended field pilot tests, supported in part by various US federal and…

Read More

NeuroBrave’s Breakthrough: Selected for Google’s AI Startup Program and Secures Major Investment

NeuroBrave, a pioneering force in cognitive and emotional technologies aimed at enhancing mental health and wellness solutions globally, has achieved a significant milestone by being selected for Google’s esteemed AI Startups Program and securing investment from the Google AI Fund. This strategic partnership marks a pivotal moment for NeuroBrave as it accelerates the development and…

Read More

Courier Health Secures $16.5 Million Investment to Revolutionize Patient Engagement in Life Sciences

Courier Health, a trailblazing technology firm dedicated to enhancing patient support within the life sciences sector, has announced a significant milestone with the closure of a $16.5 million Series A funding round. Led by Norwest Venture Partners and supported by existing investor Work-Bench, this financing underscores a pivotal moment for the company as it continues…

Read More

Command Zero Revolutionizes Cyber Investigations with $21 Million Seed Funding

Command Zero, a pioneering force in cybersecurity, emerges from stealth mode today with a significant $21 million in seed funding led by Andreessen Horowitz, alongside Insight Partners and over 60 esteemed cyber industry leaders. This funding marks a pivotal moment for the industry’s first autonomous and user-led cyber investigation platform, aimed at resolving the critical…

Read More

Octagos Health Secures $43M Series C to Propel AI-Driven Cardiac Monitoring Innovations

Octagos Health, a trailblazer in AI-driven cardiac device monitoring solutions, has successfully concluded its Series C funding round with an impressive $43 million in investment capital. The round was led by Morgan Stanley Expansion Capital, underscoring confidence in Octagos Health’s transformative technologies aimed at revolutionizing cardiac care through advanced artificial intelligence. Octagos Health specializes in…

Read More

Granza Bio Secures $7M+ Seed Funding to Propel Advanced Cancer Treatments and Genetic Medicines

Granza Bio Corporation, a trailblazing biotechnology firm rooted in pioneering therapeutic delivery platforms, has successfully concluded an oversubscribed $7.14 million Seed funding round. The funding was led by prominent investors including Felicis and Refactor, alongside participation from Y Combinator and a consortium of esteemed angel investors. Established in 2024 by distinguished researchers from the University…

Read More

Nagish Raises $16 Million to Amplify Communication for the Hearing Impaired

Nagish, a pioneering startup dedicated to enhancing communication accessibility for deaf and hard-of-hearing individuals using AI technology, has announced a significant milestone with the securing of $16 million in funding. This round includes $11 million from Series A led by Canaan Partners, with additional support from existing investors K5 Global, Tokyo Black, Cardumen Capital, Vertex…

Read More